特朗普政府周二敲定规则，将终止通过Medicaid和儿童健康保险计划(CHIP)提供的性别认同医疗的联邦资金支持[1]。该规则定于2025年10月13日生效[1]。美国卫生与公众服务部(HHS)发言人Emily Hilliard表示："美国儿童不会在没有可靠安全性和临床效益证据的情况下，由纳税人的钱进行改变人生的干预"[1]。
根据规则内容，如果政策生效，通过Medicaid和CHIP享受此类服务的儿童将被给予最多六个月时间逐步停止用药[1]。该提案最初于2024年12月首次提出，在公众征询期间收到近35,000条意见，其中约90%表示反对[1]。2025年8月3日，联邦雇员及其家属对特朗普政府的这一举措提起集体诉讼[1]，法律诉讼可能导致该规则的延迟或被阻止实施。联邦法官在4月的判决中曾指责卫生部长Robert F Kennedy Jr对法律"肆意无视"，称其行为"不安全"[1]。
The Trump administration finalized a rule on Tuesday to eliminate federal funding for gender-affirming medical care provided through Medicaid and the Children's Health Insurance Program (CHIP).[1] The rule is scheduled to take effect on October 13, 2025, though it faces potential legal challenges that could delay or prevent implementation.[1]
The proposal, first introduced in December 2024, received nearly 35,000 public comments, with approximately 90 percent expressing opposition.[1] Under the policy, children currently covered by Medicaid and CHIP will be given up to six months to gradually discontinue treatment if the rule takes effect.[1] According to HHS spokesperson Emily Hilliard, "American children will not have life-altering interventions paid for by taxpayers without reliable evidence of safety and clinical benefit."[1]
Legal action has already been initiated against the administration's plan. In August 2025, federal employees and their families filed a class-action lawsuit challenging the termination of gender-affirming medical insurance coverage.[1] Additionally, a federal judge criticized Health and Human Services Secretary Robert F. Kennedy Jr. in an April ruling, accusing him of "reckless disregard" for the law and characterizing his conduct as "unsafe."[1] Critics of the rule argue it will make healthcare access more difficult for vulnerable children and promote anti-transgender ideology contrary to medical evidence.[1]